655 related articles for article (PubMed ID: 26205241)
1. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review.
Sawaki M; Kondo N; Horio A; Ushio A; Gondo N; Adachi E; Hattori M; Fujita T; Tachibana H; Kodaira T; Iwata H
Breast Cancer; 2014 Jul; 21(4):415-22. PubMed ID: 23007312
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 10-year results with critical evaluation.
Kawamura M; Itoh Y; Kamomae T; Sawaki M; Kikumori T; Tsunoda N; Ito J; Shimoyama Y; Satake H; Naganawa S
J Radiat Res; 2020 Jul; 61(4):602-607. PubMed ID: 32494808
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
5. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Sedlmayer F; Zehentmayr F; Fastner G
Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
[TBL] [Abstract][Full Text] [Related]
6. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
[TBL] [Abstract][Full Text] [Related]
7. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
[TBL] [Abstract][Full Text] [Related]
8. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
[TBL] [Abstract][Full Text] [Related]
9. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
10. Outcome of a phase II prospective study on partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy.
Aristei C; Palumbo I; Capezzali G; Farneti A; Bini V; Falcinelli L; Margaritelli M; Lancellotta V; Zucchetti C; Perrucci E
Radiother Oncol; 2013 Aug; 108(2):236-41. PubMed ID: 24044802
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
Sawaki M; Miyamoto T; Fujisawa T; Itoh Y; Ebara T; Tachibana H; Kodaira T; Kikumori T; Yanagita Y; Iwata H
Ann Surg Oncol; 2019 Aug; 26(8):2428-2434. PubMed ID: 30993410
[TBL] [Abstract][Full Text] [Related]
12. Accelerated partial breast irradiation using only intraoperative electron radiation therapy in early stage breast cancer.
Maluta S; Dall'Oglio S; Marciai N; Gabbani M; Franchini Z; Pietrarota P; Meliadò G; Guariglia S; Cavedon C
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e145-52. PubMed ID: 22543201
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.
Meneveau MO; Petroni GR; Varhegyi NE; Hulse JC; Schroen AT; Brenin DR; Janowski EM; Berger AC; Lazar MA; Simone NL; Showalter TN; Showalter SL
Brachytherapy; 2020; 19(5):679-684. PubMed ID: 32571746
[TBL] [Abstract][Full Text] [Related]
14. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
[TBL] [Abstract][Full Text] [Related]
15. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
[TBL] [Abstract][Full Text] [Related]
17. TARGIT-E(lderly)--prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.
Neumaier C; Elena S; Grit W; Yasser AM; Uta KT; Anke K; Axel G; Marc S; Frederik W
BMC Cancer; 2012 May; 12():171. PubMed ID: 22569123
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.
Lemanski C; Azria D; Gourgon-Bourgade S; Gutowski M; Rouanet P; Saint-Aubert B; Ailleres N; Fenoglietto P; Dubois JB
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):698-703. PubMed ID: 19467579
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of proton beam accelerated partial breast irradiation in breast cancer.
Chang JH; Lee NK; Kim JY; Kim YJ; Moon SH; Kim TH; Kim JY; Kim DY; Cho KH; Shin KH
Radiother Oncol; 2013 Aug; 108(2):209-14. PubMed ID: 23891102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
